Abridge is the better ambient AI scribe with its KLAS #1 rating and unique linked evidence feature. DeepScribe is a respectable mid-tier option with a longer track record and more accessible pricing at ~$667/month. Choose Abridge for the best quality; DeepScribe for a solid option without enterprise procurement.
Key Takeaways
- Abridge is the superior choice with the #1 KLAS rating and linked evidence feature
- DeepScribe is a solid mid-tier option with broad specialty support at ~$667/month
- Abridge requires enterprise procurement; DeepScribe is more accessible for individual purchase
- For organizations that can afford enterprise pricing, Abridge is the clear winner
Abridge wins
Abridge leads with KLAS #1 rating and linked evidence; DeepScribe is a solid mid-tier option
Feature Comparison
| Feature | Abridge | DeepScribe | Winner |
|---|---|---|---|
| Industry Rating | KLAS #1 ambient AI scribe | Established but not top-rated | Abridge |
| Linked Evidence | Notes linked to conversation moments | Standard note generation | Abridge |
| Pricing | Enterprise pricing | ~$667/month per provider | DeepScribe |
| Founded | 2018 | 2017 | DeepScribe |
| Specialty Coverage | Broad specialty coverage | Broad specialty coverage | Tie |
Abridge
Best for: Enterprise health systems seeking the highest-quality ambient documentation
Strengths
- +KLAS #1 rating
- +Linked evidence feature
- +Enterprise health system adoption
- +Real-time note generation
Limitations
- -Enterprise pricing only
- -Requires organizational procurement
- -Not accessible to individual physicians
DeepScribe
Best for: Mid-size practices wanting proven ambient documentation without enterprise procurement
Strengths
- +Established since 2017
- +Broad specialty coverage
- +More accessible pricing at ~$667/month
- +Proven AI accuracy
Limitations
- -Not top-rated in KLAS
- -No linked evidence feature
- -Higher priced than budget options
- -Less differentiated than top-tier tools
Detailed Analysis
Documentation QualityAbridge
Abridge's KLAS #1 rating and linked evidence give it the clear quality edge. DeepScribe provides good documentation but without the same validation level.
AccessibilityDeepScribe
DeepScribe's ~$667/month pricing makes it accessible without enterprise procurement. Abridge requires organizational budget approval.
Track RecordTie
Both have substantial track records — DeepScribe since 2017, Abridge since 2018. Both are proven in clinical environments.
Bottom Line
Choose Abridge if you can invest in enterprise-grade ambient documentation. Choose DeepScribe if you want proven ambient AI at a per-provider price point without enterprise procurement. For tighter budgets, Freed ($99-149/month) is also worth evaluating.
Frequently Asked Questions
Is DeepScribe significantly worse than Abridge?
DeepScribe provides solid ambient documentation and is a proven tool since 2017. It is not as highly rated as Abridge, particularly lacking the linked evidence feature, but it is a respectable clinical tool.
Is $667/month worth it for DeepScribe?
At that price point, also evaluate Suki ($299-399/month) and Nuance DAX ($600-800/month). DeepScribe's value depends on your specialty needs and whether the pricing fits your practice economics.
Which supports more specialties?
Both support a broad range of specialties. Neither has a significant advantage in specialty coverage. Test with your specific specialty during evaluation.
Should I wait for Abridge to offer non-enterprise pricing?
Abridge is focused on enterprise sales. If you need ambient AI now without enterprise procurement, DeepScribe or Freed are immediate options.